U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT07479641) titled 'A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants' on March 11.
Brief Summary: This study will investigate the bioequivalence between two formulations of HRS-1893 tablets. Safety and tolerability will also be assessed.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Cardiomyopathy
Intervention:
DRUG: Test formulation of HRS-1893 tablet
Test formulation of HRS-1893 tablet, oral.
DRUG: Reference formulation of HRS-1893 tablet
Reference formulation of HRS-1893 tablet, oral.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Shandong Suncadia Medicine Co., Ltd.
Published...